Bio-Rad Laboratories, Inc.Class A vs. Bionano Genomics, Inc. Common Stock
BIO
Bio-Rad Laboratories, Inc.Class A
$382.41 +0.89%
VS BNGOBionano Genomics, Inc. Common Stock
$1.23 +2.49%
Bio-Rad Laboratories, Inc.Class A (BIO) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| BIO | BNGO | |
|---|---|---|
| Market Cap | $10.13 billion | $14.13 million |
| Revenue (TTM) | $2.59 billion | $30.18 million |
| Net Income (TTM) | $222.40 million | $-32,162,000 |
BIO leads on 3 of 3 size & scale factors.
Valuation
| BIO | BNGO | |
|---|---|---|
| P/E Ratio | 46.58 | — |
| Price / Book | 1.41 | 0.45 |
| Price / Sales | 3.91 | 0.47 |
BNGO leads on 2 of 2 valuation factors.
Profitability
| BIO | BNGO | |
|---|---|---|
| Net Margin | 8.59% | -106.58% |
| Return on Equity | 3.10% | -101.76% |
BIO leads on 2 of 2 profitability factors.
Risk & Sentiment
| BIO | BNGO | |
|---|---|---|
| Short Interest | 2.44% | 0.15% |
BNGO leads on 1 of 1 risk & sentiment factors.
Dig deeper: BIO overview, BIO financials, BNGO overview, BNGO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.